Title |
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial |
|---|---|
Involved |
Jonathan Rilinger (Verfasser)
Winfried V. Kern (Verfasser) Daniel Dürschmied (Verfasser) Alexander Supady (Verfasser)
Christoph Bode (Verfasser)
Dawid Staudacher (Verfasser) Tobias Wengenmayer (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Trials 21, 1, 3.6.2020, date:12.2020, Seite 1-3 |
Published |
2020 |
Language |
|
Country |
|
Topic |
|
Subject |
Medicine/Public Health, general. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2020080500073921863891 (URN) |
Record ID |
1215173954 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: